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shown that di~y~damo~e 
et al. (1) have extended 
strating that dipy~damo~e thallium scinti 
identifying patients with chronic c 
risk for future myocardia~ infarctio 
ease who cannot 
e observations build on the earlier pioneering work 
st et al. (5), who demonstrated the ability to differ- 
entiate transiently ischemic myocardium from infarcted myo- 
cardium by serial imaging after a single dose of thallium-201 
and by Gibson et al. (6) and Kaul et al. (7), who showed that 
thallium-201 scintigraphy with exercise allows one to iden- 
tify patients with coronary heart disease at risk for future 
coronary events. The greatest value of dipyridamole thal- 
lium-201 scintigraphy is that it may be used in patients who 
cannot or will no: exercise as well as in patients in whom 
vigorous exercise testing may not be safe, including those 
to tailor subsequent 
predict prognosis nsu 
consequent alteration i prognosis. Additional comparisons 
of the prognostic utility of fixed perfusi 
reversible ~e~~sio~ defects using the 
need to be made. 
I sciritigraphy are of some concern. 
stantial number of patients develop 
angina soon after dipyridamole is a inistered. In general, 
the angina is related to an increase cart rate, decrease in 
blood pressure and, sometimes, an actual decrease incoro- 
nary blood flow to an ischemic region. However, the in- 
crease in heart rate and reduction i blood pressure may be 
rapidly reversed by the intravenous administration f ami- 
nophylline, and they rarely lead to an untoward clinical 
event in patients with stable coronary heart disease. Never- 
theless, one should be careful in using such methods in 
patients with a recent history of increasingly frequent chest 
pain or chest pain occurring at low levels of effort or at rest, 
or both, because the induction of ischemia in these individ- 
uals might, on occasion, be associated with more important 
clinical events. 
*Editorials published in Journal of rho American College of Cardiology 
reflect the views of the authors and do not necessarily represent the views of 
JACC or the American College of Cardiology. 
From the Department of Internal Medicine, University of Texas Medical 
Sch ston, Texas. 
: James T. Willerson. MD, Departmeal of Internal 
I. Hendel RC. Layden JJ. Leppo JA. Prognostic value of dipyridamole 
thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll 
Cardiol 1990:15:109-16. 
Medicine, University of Texas Medical School at Houston. P. 0. Box 20708. 
Houston, Texas 77025. 2. Boucher CA, Brewster DC, Darling RC. Okada RD. SI~~USS HW. P&St 
81990 by the American College of Cardiology 
073sm97/901%3.50 
118 WILLERSON 
EDITORIAL COMMENT 
JACC Vol. 15. No. 1 
January I :117-g 
GM. Determination f cardiac risk by dipyridamole-thallium imaging dium by serial imaging after a single dose of thallium-201. Circulation 
before peripheral vascular surgery. N Engl J Med 1985:312:389-94. 1977;55:294-304. 
3. Sachs RN, TeUier P, Lannignat P, et al. Assessment by dipyridamole- 
thallium-201 myocardial scintigraphy of coronary risk before peripheral 
vascular surgery. Surgery l98%103:584-7. 
4. Leppo JA, O’Brien J, Rotwendler JA, Getchell JD, Lee VW. Dipyridam- 
ale-thallium-201 scintigraphy in the prediction of future cardiac events 
after acute myocardial infarction. N Engl J Med 1984;310:1014-8. 
5. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. 
DitTerentiation of transiently ischemic myocardium from infarcted myocar- 
6. Gibson RS, Watson DD. Craddock GB. et al. Prediction of cardiac events 
after uncomplicated myocardial infarction: prospective study comparing 
predischarge exercise thallium-201 scintigraphy and coronary angiography. 
Circulation 1986;68:321-36. 
7. Kaul S, Lilly DR. Gascho JA, et al. Prognostic utility of the exercise 
thallium-201 test in ambulatory patients with chest pain: comparison with 
cardiac catheterization. Circulation 1988:77:745-58. 
